Published by Josh White on 27th May 2022
(Sharecast News) - RUA Life Sciences reported increased sales growth in a full-year trading update on Friday, amid recovery from Covid-19 disruption and advances in its business processes and management to minimise the risk of a further delay to the regulatory approval of RUA Vascular's graft range.